“We are now positioned for extraordinary growth at Mycell Technologies and Oceans Omega, our flagship ingredient subsidiary,” said Benjamin D. Mamola, Chairman and Chief Executive Officer.
“We are thankful to have a strategic institutional investor to share in this growth. In the coming weeks, we will be announcing additions to our management team and new partnerships to help continue our strong momentum.”
Terms of the transaction and investor names were not disclosed.